Encision (Encision) GF Value : $0.46 (As of Apr. 26, 2024)

View and export this data going back to 1996. Start your Free Trial

What is Encision GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-26), Encision's share price is $0.44. Encision's GF Value is $0.46. Therefore, Encision's Price-to-GF-Value for today is 0.96.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Encision is Fairly Valued.

Encision (OTCPK:ECIA) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Encision's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	0.44	/	0.46
	=	0.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encision GF Value Related Terms

Thank you for viewing the detailed overview of Encision's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Encision (Encision) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Encision Inc (OTCPK:ECIA) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

6797 Winchester Circle, Boulder, CO, USA, 80301

Website

https://www.encision.com

Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally-invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.

Executives

Robert H Fries	director	800 FILLMORE ST, DENVER CO 80206
Peter D Geary	officer: VP of Operations	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Jason E Johnson	officer: VP Sales	17752 WEDGEWOOD LANE, PRIOR LAKE MN 55372
Patrick R Dixon	director	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Gregory J. Trudel	director, officer: CEO	5241 RIMROCK LANE, FORT COLLINS CO 80526
Brian J Jackman	director	6797 WINCHESTER CIRCLE, SUITE 100, BOULDER CO 80301
Von Der Lippe Paul	director	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Denise Baker	director	6797 WINCHESTER CIRCLE, BOULDER X1 80301
Vern D Kornelsen	director, 10 percent owner	4605 S. DENICE DR, ENGLEWOOD CO 80111
Partners Lllp Cmed	10 percent owner
Patrick W Pace	director	3701 SOARING EAGLE, AUSTIN TX 78746
Michael Biggs	officer: VP Engineering	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Brad Greathouse	officer: VP RA/QA	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Valerie Ray	officer: VP of Operations	6797 WINCHESTER CIRCLE, BOULDER CO 80301
David W Newton	director, officer: VP Technology	8099 NORTH 63RD STREET, LONGMONT CO 80503